| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.009 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.009 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |